The study of the new regimen of the AZT administration to the neonate for preventing HIV mother-to-child transmissio
Not Applicable
- Conditions
- HIV
- Registration Number
- JPRN-UMIN000008935
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
The mother rejects the agreement for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)HIV transmission at 1 year and 6 month: HIV antibody detection 2)The degree of born marrow suppression: The minimum number of hemoglobin, white blood cell, neutrophile count, platelet between initial AZT administration and 1 or 2 months after completion.
- Secondary Outcome Measures
Name Time Method